Back to search

Oestrogen effects on calcitriol levels in post‐menopausal women: a comparison of oral versus transdermal administration

Data up to Jan 2025

Published1995
Citations43
References25

Total Citations Per Year

Abstract

References (25)

Estrogen Binding, Receptor mRNA, and Biologic Response in Osteoblast-Like Osteosarcoma Cells

1988 • 836 citations

Prevention of Postmenopausal Osteoporosis

1991 • 554 citations

Contrasting Effects of Oral and Transdermal Routes of Estrogen Replacement Therapy on 24-Hour Growth Hormone (GH) Secretion, Insulin-Like Growth Factor I, and GH-Binding Protein in Postmenopausal Women*

1991 • 510 citations

Influence of the Vitamin D-binding Protein on the Serum Concentration of 1,25-Dihydroxyvitamin D3

1981 • 507 citations

Biologic effects of transdermal estradiol

1987 • 467 citations

Effect of Estrogen on Calcium Absorption and Serum Vitamin D Metabolites in Postmenopausal Osteoporosis*

1980 • 433 citations

Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure.

1986 • 302 citations

Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement

1985 • 282 citations

Biological Effects of Various Doses of Conjugated Equine Estrogens in Postmenopausal Women*

1980 • 194 citations

Effects of different oral oestrogen formulations on insulin‐like growth factor‐I, growth hormone and growth hormone binding protein in post‐menopausal women

1993 • 168 citations

Effects of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women.

1989 • 154 citations

Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones

1985 • 150 citations

COUNTERPOINT: Estrogen Effects on Calcitropic Hormones and Calcium Homeostasis

1994 • 130 citations

Early Postmenopausal Bone Loss is Not Associated with a Decrease in Circulating Levels of 25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D, or Vitamin D-Binding Protein*

1987 • 107 citations

SERUM FREE 1,25‐DIHYDROXYVITAMIN D AND THE FREE 1,25‐DIHYDROXYVITAMIN D INDEX DURING A LONGITUDINAL STUDY OF HUMAN PREGNANCY AND LACTATION

1990 • 90 citations

THE EFFECT OF TRANSDERMAL OESTROGEN ON BONE, CALCIUM‐REGULATING HORMONES AND LIVER IN POSTMENOPAUSAL WOMEN

1986 • 56 citations

Effect of oestrogen and 1,25-dihydroxycholecalciferol on 25-hydroxycholecalciferol metabolism in primary chick kidney-cell cultures

1978 • 55 citations

Effects of Transdermal Estrogen Replacement on Parathyroid Hormone Secretion

1990 • 55 citations

The Effects of the Menopause on Calcitriol and Parathyroid Hormone: Responses to a Low Dietary Calcium Stress Test*

1990 • 50 citations

25(OH)D3 metabolism in kidney cell cultures: lack of a direct effect of estradiol

1981 • 39 citations

Progestin antagonism of estrogen stimulated 1,25-dihydroxyvitamin D levels.

1992 • 36 citations

Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin d, and parathyroid hormone in postmenopausal women

1990 • 36 citations

Progestin antagonism of estrogen stimulated 1,25-dihydroxyvitamin D levels

1992 • 30 citations

Comparison of the performance and clinical utility of a carboxy-terminal assay and an intact assay for parathyroid hormone

1988 • 27 citations

Chromatography of serum on Sep-pak C18 corrects falsely elevated vitamin D metabolite levels measured by protein binding assay

1988 • 24 citations

Cited By (0)

Loading...